In Body Composition Analysis Technology
In the early 1990s, ‘InBody’ founder and CEO Dr. Kichul Cha recognized that the available ‘BIA devices’ were limited and faulty. BIA devices were often inaccurate, and from a medical standpoint, useless for helping patients who needed body composition analysis the most. Drawing from his background in mechanical engineering, he set to work and design something better.
In 1996, he founded ‘InBody’. Two years later, the first ‘InBody device’ was born. Today, InBody has grown from a small biotech startup in South Korea to a multinational corporation with branches and distributors in more than 80 countries. Its clients trust it to provide precise, practical, and accurate body composition data to their users because they know that InBody combines convenience, accuracy, and reproducibility into one easy-to-use device.
InBody was founded in South Korea. Products feature direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA) and an eight-point tactile electrode system to measure an individual’s body composition without the use of empirical data.
It established its first overseas subsidiary in Beverly Hills, California. InBody technology is FDA-approved and results have been validated by research. Its mission is To provide biomedical technology that simplifies the understanding of your health and wellness.